Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma

Russell F Palm1, Heather S L Jim2, David Boulware3

  • 1Department of Radiation Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

Summary

Weekly symptom reporting using the Revised Edmonton Symptom Assessment Scale (ESAS-r-CSS) during pre-operative radiotherapy for retroperitoneal sarcoma (RPS) helped manage patient anxiety and pain. This proactive approach can minimize symptom progression and treatment interruptions.